CN1401237A - Animal ectoparasite preventing and treating agent - Google Patents
Animal ectoparasite preventing and treating agent Download PDFInfo
- Publication number
- CN1401237A CN1401237A CN 02139332 CN02139332A CN1401237A CN 1401237 A CN1401237 A CN 1401237A CN 02139332 CN02139332 CN 02139332 CN 02139332 A CN02139332 A CN 02139332A CN 1401237 A CN1401237 A CN 1401237A
- Authority
- CN
- China
- Prior art keywords
- agent
- preventing
- rotenone
- animals
- animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 45
- 244000078703 ectoparasite Species 0.000 title claims abstract description 22
- 229940080817 rotenone Drugs 0.000 claims abstract description 42
- JUVIOZPCNVVQFO-UHFFFAOYSA-N rotenone Natural products O1C2=C3CC(C(C)=C)OC3=CC=C2C(=O)C2C1COC1=C2C=C(OC)C(OC)=C1 JUVIOZPCNVVQFO-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 25
- 239000005660 Abamectin Substances 0.000 claims abstract description 12
- 239000004094 surface-active agent Substances 0.000 claims abstract description 9
- 239000002904 solvent Substances 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 239000000839 emulsion Substances 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 11
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 8
- -1 polyoxyethylene nonylphenol Polymers 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 229910019142 PO4 Inorganic materials 0.000 claims description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 7
- 239000010452 phosphate Substances 0.000 claims description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- RNMDNPCBIKJCQP-UHFFFAOYSA-N 5-nonyl-7-oxabicyclo[4.1.0]hepta-1,3,5-trien-2-ol Chemical compound C(CCCCCCCC)C1=C2C(=C(C=C1)O)O2 RNMDNPCBIKJCQP-UHFFFAOYSA-N 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- GWGMICQFGXMPAU-UHFFFAOYSA-N S=[Ca].OC1=CC=CC=C1 Chemical compound S=[Ca].OC1=CC=CC=C1 GWGMICQFGXMPAU-UHFFFAOYSA-N 0.000 claims description 2
- 239000003599 detergent Substances 0.000 claims description 2
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 229940051841 polyoxyethylene ether Drugs 0.000 claims description 2
- 229920000056 polyoxyethylene ether Polymers 0.000 claims description 2
- 229920001451 polypropylene glycol Polymers 0.000 claims description 2
- MJEMIOXXNCZZFK-UHFFFAOYSA-N ethylone Chemical compound CCNC(C)C(=O)C1=CC=C2OCOC2=C1 MJEMIOXXNCZZFK-UHFFFAOYSA-N 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 11
- 238000012545 processing Methods 0.000 abstract description 7
- 239000000575 pesticide Substances 0.000 abstract description 5
- 239000013543 active substance Substances 0.000 abstract description 3
- 230000000035 biogenic effect Effects 0.000 abstract description 3
- 230000015556 catabolic process Effects 0.000 abstract description 2
- 238000006731 degradation reaction Methods 0.000 abstract description 2
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 abstract 1
- 206010059866 Drug resistance Diseases 0.000 abstract 1
- 229950008167 abamectin Drugs 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 45
- 241000283973 Oryctolagus cuniculus Species 0.000 description 30
- 206010039509 Scab Diseases 0.000 description 26
- 229940079593 drug Drugs 0.000 description 25
- 238000012360 testing method Methods 0.000 description 24
- 241001494479 Pecora Species 0.000 description 17
- 244000144972 livestock Species 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 241001674048 Phthiraptera Species 0.000 description 8
- 201000002266 mite infestation Diseases 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 6
- 238000009395 breeding Methods 0.000 description 6
- 230000001488 breeding effect Effects 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 244000144977 poultry Species 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 230000003071 parasitic effect Effects 0.000 description 5
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 206010000351 Acariasis Diseases 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 210000003194 forelimb Anatomy 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 230000009931 harmful effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 241000238876 Acari Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 206010048865 Hypoacusis Diseases 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 241000509427 Sarcoptes scabiei Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000000078 claw Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 210000000959 ear middle Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000361 pesticidal effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- RFEJUZJILGIRHQ-XRIOVQLTSA-N 2,3-dihydroxybutanedioic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound OC(=O)C(O)C(O)C(O)=O.OC(=O)C(O)C(O)C(O)=O.CN1CCC[C@H]1C1=CC=CN=C1 RFEJUZJILGIRHQ-XRIOVQLTSA-N 0.000 description 1
- 241000203989 Anoplocephalidae Species 0.000 description 1
- 241000238888 Argasidae Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000245588 Baptisia Species 0.000 description 1
- 241001232809 Chorista Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000179420 Haemaphysalis longicornis Species 0.000 description 1
- 101710138657 Neurotoxin Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000006650 Overbite Diseases 0.000 description 1
- 241000283903 Ovis aries Species 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010041954 Starvation Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 201000008680 babesiosis Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000010242 baoji Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- OOCMUZJPDXYRFD-UHFFFAOYSA-L calcium;2-dodecylbenzenesulfonate Chemical compound [Ca+2].CCCCCCCCCCCCC1=CC=CC=C1S([O-])(=O)=O.CCCCCCCCCCCCC1=CC=CC=C1S([O-])(=O)=O OOCMUZJPDXYRFD-UHFFFAOYSA-L 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 239000013057 ectoparasiticide Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 210000004744 fore-foot Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000002581 neurotoxin Substances 0.000 description 1
- 231100000618 neurotoxin Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000024241 parasitism Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention discloses an animal ectoparasite preventing and treating agent, which is prepared by taking rotenone and abamectin as effective components, adding a solvent, a surfactant and the like, and mixing the components. The agent is composed of biogenic active substances, and has a degradation way in the environment, so the agent has no influence on the environment after being used, and animal ectoparasites are not easy to generate drug resistance to the animal ectoparasites; the pesticide preparation processing means is adopted, so that the preparation is reasonable in dosage form and convenient to use; has high efficiency of killing animal ectoparasites, has little influence on animals, is safe, and is a pollution-free animal ectoparasite control agent.
Description
One, affiliated field
The invention belongs to a kind of desinsection, insect-proof agent in the livestock breeding animal, relate to a kind of control agent, particularly a kind of animal body agent for preventing and controlling ectoparasite.
Two, background technology
Ecotozoa mainly comprises monoids such as mite, tick and lice.Mite, tick and lice of a great variety, widely distributed, very serious to animal is very big to the animal husbandry economy influence.
Mite can endanger ox, sheep, pig, horse, dog, rabbit, fowl and many wildlifes, the positions such as skin, feather and air bag that it parasitizes animal can cause that the animal play itches, illnesss such as depilation and pachyderma, by the animal of mite parasitism, show as and become thin, dysphoria, can not normally take food and rest.Mite also secretes a large amount of toxin in parasitic processes, the digestion and absorption function of animal and the defence capability of body are reduced, and animal skin be full of cracks, hemorrhage secondary infection finally cause death when serious.The mite class can cause multiple infectious disease, and as propagating Richettsia, virus and bacteriosis, mite still is the intermediate host of Anoplocephalidae tapeworm.
Tick claims flat lice or ox louse again, is the epizoa that most of terrestrial vertebrates can both obligate be sucked blood.Comprise three sections: hard tick section, soft ticks section and receive tick section, wherein the most common, harm is hard tick section to the maximum.Tick is sucked host's blood, can cause animal uneasiness, anaemia when a large amount of parasitic, become thin, depauperation, the fur quality reduces and milk production under degradation.And also secrete a kind of neurotoxin in the process of sucking blood, the secondary bacterial infection is the disseminate media and the reservoir host of many pathogene.Can cause multiple piroplasmosis and some infectious disease of domestic animal.Lice to the harm of livestock and poultry not as mite, tick is big but volume also can have a strong impact on growing of livestock and poultry when parasitic, reduces its productivity.
Another kind of epizoa lice, though the harm of livestock and poultry is not had tick, mite is serious, and volume also can have a strong impact on growing of livestock and poultry when parasitic, and when livestock and poultry entered age campaign, a large amount of parasitic of lice can reduce its production capacity.
Because ecotozoa produces influence greatly to livestock breeding, harm is serious.So, be important process during livestock breeding is produced to the verminal control of livestock and poultry.At present, ectoparasiticide thing commonly used both at home and abroad mostly is chemicals, wherein a lot of kinds are big to animal toxicity, use the back that feed, the activity of animal are all had considerable influence, and big to the pollution of environment, the livestock products quality there is harmful effect, and long-term the use, epizoa has produced resistance to various medicaments wherein, suddenly waits to develop the agent for preventing and controlling ectoparasite of efficient, low toxicity, low-residual, solves the ectozoic difficult problem of preventing and treating in the livestock breeding.
Three, summary of the invention
The objective of the invention is to, provide a kind of height is imitated in insect protected, little to animal toxicity, the agent for preventing and controlling ectoparasite of animals of environmentally safe.
The present invention to the epizoa activity research, filters out plant resource material rotenone by multiple biogenic active substance, these two kinds of reactive compounds of microbial source material Avermectin, studies show that, these two kinds of materials are to epizoa preventive effect height, and are little to animal toxicity, environmentally safe.
Rotenone is a contained active component in trifoliate jewelvine, the Baptisia plant, is used for the control of plant insect and mite more, and the report of application is not also arranged in preventing and controlling ectoparasite of animals.Avermectin is to be got by microbial fermentation, and they are many in preventing and controlling ectoparasite of animals to use with the hypodermic injection method, because hypodermic injection is big to the animal influence, after the injection Avermectin, just can slaughter after 3 months, so its application is subjected to certain restriction.
Rotenone, the Avermectin compound formulation of this research invention are used the be mixed principle of synergy of Pesticidal products, adopt the preparation processing means, make this compound formulation formulation reasonable, easy to use, use the back that feed, the activity of animal are not all had influence.On conceived sheep body, carry out body surface spray, wipe deeply, conceived sheep has no adverse reaction.Show epizoa is killed efficiently, animal is not had influence, the characteristics that environmental pollution is little.
The technical scheme that the present invention takes is: this agent for preventing and controlling ectoparasite of animals, be characterized in, and be effective ingredient with rotenone, Avermectin, add solvent, materials such as surfactant are mixed and form, and the percentage by weight of each component is:
Rotenone 0.1%~99.0%
Avermectin 0.0~2.0%
Solvent 50.0%~80.0%
Surfactant 5.0%~20.0%
This agent can be made into missible oil or aqueous emulsion, and converting water during use becomes emulsion, and spray quinoline or wipe deeply in the infected animal body surface parasitizes the various parasites such as tick, mite, lice of animal body surfaces such as pig, ox, sheep, rabbit with control.
Solvent for use can be water or deionized water or methyl alcohol in the preparation processing, or ethanol, or propyl alcohol, or one or more mixtures in the material known altogether of ethyl acetate or this area staff; Surfactant is a polyoxyethylene nonylphenol ether, or detergent alkylate sulphur phenol calcium, or the alkyl polyoxyethylene ether phosphate, or alkyl polyoxypropylene ether phosphate, or one or more mixtures in the speciality known altogether of polyoxyethylene nonylphenol ether phosphate or this area staff.
The present invention compares with existing agent for preventing and controlling ectoparasite of animals, and following advantage is arranged:
1. this agent is made up of the biogenic active substance, and the approach of its degraded is arranged in environment, so use the back that environment is not had influence, ecotozoa is difficult for should giving birth to pesticide resistance to it;
2. the pesticidal preparations manufacturing process is adopted in this agent, makes preparation formulation reasonable, and is easy to use;
3. this agent is to ecotozoa kill efficiency height, and little to the animal influence, safety is a kind of non-harmful agent for preventing and controlling ectoparasite of animals.
Four, embodiment
For a more clear understanding of the present invention and the drug effect of medicament of the present invention, below the following embodiment that finishes according to technical solution of the present invention that provides by the inventor the present invention is described in further detail, these only are the present invention embodiment preferably, but are not limited to these embodiment.
Embodiment 1: according to technical scheme of the present invention, take by weighing 15% rotenone (below be weight ratio) 25.0g, and polyoxyethylene nonylphenol ether phosphate 10.0g, calcium dodecyl benzene sulfonate 10.0g is dissolved in above three kinds of materials in the isopropyl alcohol; Take by weighing the 55.0g deionized water in homogenizer, the aqueous isopropanol with materials such as rotenone under high-speed stirred is added dropwise in the homogenizer, promptly makes rotenone water emulsion.
Embodiment 2: according to technical scheme of the present invention, take by weighing 15% rotenone 15.0g, 6.5% Avermectin ointment 3.0g (containing pure Avermectin 1.95%), be dissolved in the 72.0g ethanol, under agitation add the 10.0g OPEO, promptly make rotenone A Wei missible oil.
Certainly, adopt the each component in the percentage by weight of the present invention to prepare, can be made into the missible oil or the aqueous emulsion of series, for different animals, as domestic animals, the external various parasites such as mite, tick and lice of bird prevent and treat all is effective, as the span of rotenone between 0.1%~99.0%, Avermectin is between 0~2.0%, solvent is between 50.0%~80.0%, surfactant is between 5.0%~20.0%, the example of above-mentioned preparation can be listed various, and the present invention does not enumerate one by one at this.
EXPERIMENTAL EXAMPLE 1: use rotenone water emulsion, rotenone A Wei missible oil has carried out killing the test of haemaphysalis longicornis.Test chorista tickicide and the clinical blood tick of killing are tested.1.1 experimental animal
Selection Baoji boolean mutton sheep breeding is all raised the boolean mutton sheep of herding naturally in two districts 35 (no lambs) and is tested as the clinical medicine tickicide.Record overbit before the test, and by an infection intensity of statistics body surface tick.1.2 test method: the 1.2.1 tickicide test method that exsomatizes
The plate medicine embrane method is adopted in the tickicide test of exsomatizing.The tick (one-tenth tick) of living is taked from the sheep body in the scene before the test, selects the strong person of vigor to use.Each chemicals treatment with 20 ticks (
: ♀=3: 2), with the exsomatize tickicide test of plate medicine embrane method, other establishes the plate moisture film and organizes in contrast.Every the death condition that 8h observes a tick, record 24h respectively tests the death toll of tick, and calculates its tickicide rate.1.2.2 the clinical tickicide test of pesticide effectiveness
The clinical rotenone water emulsion of establishing, two processing of rotenone A Wei missible oil.Rotenone water emulsion is diluted to contain rotenone be 0.075%; Rotenone A Wei missible oil is diluted to and contains trifoliate jewelvine 0.0375%.Every drug test group infects sheep with 5 and carries out the body surface spraying.During spraying tick is stung the bigger position spraying of attached density and strengthen, thoughtful to the spraying that chest, abdomen, four limbs inboard etc. are located.With the clear water processed group is contrast.
At random carry out the observation of sheep body tick by experimental group every day after the medication, checks clinical symptoms, observes, writes down the drinking-water, appetite, spirit of sheep etc. simultaneously, judges the safety of sheep after the medication and non-toxic reaction is arranged with this.Till infecting new tick again.1.2.3 medicament is killed the calculating of rate to tick
72h after the medication by the whole ticks on each experimental group collection sheep body, judges death condition, calculates the kill rate of medicament to tick with following formula.
The tickicide test of pesticide effectiveness 1.3 result of the test 1.3.1 exsomatizes
Rotenone water emulsion, the stripped tickicide result of the test of rotenone A Wei missible oil variable concentrations processing etc. sees Table 1.
Two kinds of medicaments of table 1 tickicide result of the test (plate medicine embrane method) that exsomatizes
Medicament | Concentration (containing rotenone) % | Death toll | Killing rate % |
Rotenone water emulsion | 0.01 | 8 | 40.0 |
0.02 | 12 | 60.0 | |
0.04 | 14 | 70.0 | |
0.08 | 18 | 90.0 | |
Rotenone A Wei missible oil | 0.01 | 12 | 60.0 |
0.02 | 16 | 80.0 | |
0.04 | 20 | 100.0 |
Result of the test shows that two kinds of medicaments of the present invention have very high killing rate to tick under isolated condition.1.3.2 the clinical tickicide test of pesticide effectiveness
The clinical tickicide drug effect result of the test of medicament sees Table 2.
The clinical tickicide result of the test of two kinds of medicaments of table 2
Medicine was observed the repellent phase of tick: observe by clinical trail, find two kinds of medicaments under above-mentioned two kinds of concentration are handled, the processed group sheep infects the time of tick again at 20-30 days, and drug effect is better.Sheep is only spiritual in the process of the test, appetite, all no abnormal reaction of defecation, and pregnant ewe also has no adverse reaction.
Medicament | Concentration (containing rotenone) % | The average infection intensity of group before the medication (only/sheep) | 72h sheep body surface tick cell mean alive after the medication (only/sheep) | Kill rate % |
Rotenone water emulsion | ????0.0750 | ????127 | ??12.0 | ??90.55 |
Rotenone A Wei missible oil | ????0.0375 | ????141 | ??12.0 | ??91.49 |
Experimental example 2: medicament is killed Sarcoptes suis and is tested 2.1 experimental animals
The typical stock boar of symptom and the breeding sow of psoroptic mange suffered from kind pig farm, Xibei Univ. of Agricultural ﹠ Forest Science ﹠ Technology herding station, and totally 5, this pig had inoculated escherichia coli seedling before the test.2.2 experimental design
Three groups are set up in experiment separately, treat one group with rotenone water emulsion of the present invention; Treat one group with rotenone A Wei missible oil of the present invention; The 3rd group of pig do not do any processing.Except that rotenone A Wei missible oil treatment group be two pigs (one 8 age boar, one 24 the monthly age farrowing sow) all the other two treatment groups be one 24 the monthly age boar.2.3 experimental implementation
Except that control group, every group of pig medication secondary, it is spaced apart 7 days.Rotenone water emulsion treatment group: medicine is sprayed on the pig surface by 1: 1000 dilution back with watering can, embrocates evenly with shoe brush simultaneously, do not stay the dead angle; Rotenone A Wei missible oil treatment group: the medicine for preparing is sprayed on the pig surface by 1: 1000 dilution back with watering can, embrocates evenly with shoe brush simultaneously, do not stay the dead angle; The 3rd group: do not do any processing.Pig after the medication only all divides circle to raise, and regularly to pig symptom only, record is observed and carried out in clinical manifestation.2.4 the pig body kills the clinical manifestation before the mite result of the test 2.4.1 medication
The hard of hearing portion of pig of the suffering from psoroptic mange thick crust of 1cm of having an appointment, skin is full split hemorrhage, the coarse hardening of touching, there is the canescence crust head, eye, cheek, there are a large amount of white crusts at the back, some is full split hemorrhage, the coarse hardening of touching, trunk both sides canescence crust, rubefaction, there is the canescence crust four limbs and oxter, and there is the big bronzing scab of grain of rice piece two forelimbs and oxter, about the about 2mm of thickness, that touches is hard slightly.The pars affecta skin dorsal body setae comes off, and the pig gargalesthesia is violent, rubs on the circle wall every now and then, rubs forelimb and oxter with hind leg sometimes, and sick pig becomes thin, spirit difference and irritated.2.4.2 the clinical manifestation after the medication
After medication the 7th day, respectively medication group pig is gathered pathological material of disease, put into plate separately after the numbering, add a cover, put into 40 ℃ of water-bath 30min after, examining under a microscope does not all have mite alive and climbs out of.Each medication group pig back crust begins to soften, crust around the pig ear of rotenone A Wei preparation group comes off, back some places crust also comes off, ear middle part scab piece is dry and cracked, stopped bleeding and incrustation, and medication group pig is obviously than quiet before the medication, and control group pig back canescence crust obviously thickens, and the some places be full of cracks is hemorrhage serious, and ear's crust thickens, and the oxter crust thickens.After medication the 14th day, the rotenone water emulsion group had a little crust except that the ear middle part of pig, and all the other all come off, and expose pink skin.After medication the 21st day, rotenone water emulsion and the complete obiteration of rotenone A Wei preparation group Sarcoptes suis disease symptoms, affected part grows virgin wool, and the pig state of mind is good.Control group pig crust is thicker, and the skin be full of cracks is hemorrhage serious, and the gargalesthesia aggravation is become thin, and the pig state of mind is very poor.
Experimental example 3: medicament is killed the rabbit mite and is tested 3.1 experimental animals:
The common rabbit (part is bought healthy rabbits and duplicated case with artificial infection's method from the fairground, a part is directly purchased the rabbit that suffers from acariasis) that suffers from acariasis.Every rabbit all inoculates rabbit Pasteurella, rabbit pest, clostridieum welchii triple vaccine before testing.3.2 test operation
Rotenone water emulsion (1000 accompany dilution), rotenone A Wei preparation (1500 accompany dilution) and clear water contrast are established in test.Except that control group, medicine was wiped 3 days continuously, guaranteed not stay the dead angle every day 1 time at every turn, and the affected part crust is left intact when handle handling, and three groups of rabbit groupings are raised after the medication, after the medication to rabbit symptom, clinical manifestation observe, record.2.3 the rabbit body kills clinical manifestation and symptom before the mite result of the test 2.3.1 medication
The rabbit fore paw of suffering from chorioptic mange is come off by hair, and nail is exposed, and preceding claw covers the linen thick scab of one deck, touches hardly, and rabbit has the action of shaking claw frequently; Forming a scab fully, harden in the hind leg landing part, is come off by hair, has when rabbit reposes and do not stop the performance that the change of feet lands, and around the nose of rabbit, the lip tangible incrustation arranged all, and the action of shaking forelimb is arranged.
Suffer from the rabbit of otoacariasis, show as the yellow-white crust that has filled up numb pattern in the duct, ear is sagging, and the performance of shaking the head is arranged frequently, and hard of hearing blood vessel is obviously congested.
Suffer from chorioptic mange and the rabbit that suffers from otoacariasis all show spirit depressed, become thin, search for food, having a rest is greatly affected.2.3.2 clinical manifestation after the medication and symptom
After medication the 7th day, respectively each group rabbit is gathered pathological material of disease, the plate of putting into after the numbering is separately added a cover, put into 40 ℃ of water-bath 30min after, examining under a microscope does not all have mite alive and climbs out of.The crust that examination is respectively organized on the rabbit four limbs is obviously softening, and the crust around the rabbit lip of chemicals treatment group comes off, and crust is dry and cracked in the external auditory meatus, respectively organizes rabbit simultaneously obviously than quiet before the medication, and feed intake also increases to some extent.Linen crust obviously thickens around the control group rabbit lip, and front foot is come off fully by hair, and numb pattern yellowish-brown crust thickens in the ear.
After medication the 14th day, the symptom of chemicals treatment group was similar to the 7th day, and rabbit limb portion only leaves the crust of pin front portion, and the remainder crust all comes off, and forelimb is similar to hind leg.Control group rabbit spirit is depressed, poor appetite, ear and the foot symptom is bright increases the weight of.
After medication the 14th day, the symptom complete obiteration of rotenone water emulsion (1000 accompany dilution), rotenone A Wei preparation (1500 accompany dilution) processed group rabbit acariasis.Affected part has grown virgin wool, and ear is upright.This moment, the control group rabbit was only surplus 1.This rabbit skeletonize, appetite is useless exhausted, in 24h death.The control group rabbit is after death cutd open inspection and is not all found obvious pathological change, rabbit stomach inanition.
Prove by above test examples, agent for preventing and controlling ectoparasite of animals of the present invention, to ecotozoa kill efficiency height, little to the animal influence, safety is a kind of non-harmful agent for preventing and controlling ectoparasite of animals.
Claims (4)
1. an agent for preventing and controlling ectoparasite of animals is characterized in that, this agent for preventing and controlling ectoparasite of animals is to be effective ingredient with rotenone, Avermectin, adds solvent, and materials such as surfactant are mixed and form, and the percentage by weight of each component is:
Rotenone 0.1%~99.0%
Avermectin 0.0~2.0%
Solvent 50.0%~80.0%
Surfactant 5.0%~20.0%
2. agent for preventing and controlling ectoparasite of animals as claimed in claim 1 is characterized in that this agent can be made into missible oil or aqueous emulsion, and converting water during use becomes emulsion.
3. agent for preventing and controlling ectoparasite of animals as claimed in claim 1 is characterized in that, described solvent can be a water, or deionized water, or methyl alcohol, or ethanol, or propyl alcohol, or ethyl acetate, or one or more mixtures in the vehicle substance known altogether of this area staff.
4. agent for preventing and controlling ectoparasite of animals as claimed in claim 1, it is characterized in that, described surfactant is a polyoxyethylene nonylphenol ether, or detergent alkylate sulphur phenol calcium, or alkyl polyoxyethylene ether phosphate, or alkyl polyoxypropylene ether phosphate, or polyoxyethylene nonylphenol ether phosphate, or one or more mixtures in the surfactant materials known altogether of this area staff.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02139332 CN1401237A (en) | 2002-08-05 | 2002-08-05 | Animal ectoparasite preventing and treating agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02139332 CN1401237A (en) | 2002-08-05 | 2002-08-05 | Animal ectoparasite preventing and treating agent |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1401237A true CN1401237A (en) | 2003-03-12 |
Family
ID=4750037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02139332 Pending CN1401237A (en) | 2002-08-05 | 2002-08-05 | Animal ectoparasite preventing and treating agent |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1401237A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100397989C (en) * | 2005-11-21 | 2008-07-02 | 河北威远生物化工股份有限公司 | Disinsection emulsion in water containing avermectin |
CN1985594B (en) * | 2006-12-04 | 2010-08-18 | 上海农乐生物制品股份有限公司 | Preparing process of rotenone water emulsion |
CN101991522A (en) * | 2010-11-03 | 2011-03-30 | 华南理工大学 | Tick repellent toilet water and preparation method thereof |
CN102037979A (en) * | 2010-10-26 | 2011-05-04 | 张炳泉 | Pesticide preparation for prevention and control of ticks |
CN102657712A (en) * | 2012-05-30 | 2012-09-12 | 中国农业科学院兰州畜牧与兽药研究所 | Preparation method for adonis coerulea maxim extract and application thereof |
-
2002
- 2002-08-05 CN CN 02139332 patent/CN1401237A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100397989C (en) * | 2005-11-21 | 2008-07-02 | 河北威远生物化工股份有限公司 | Disinsection emulsion in water containing avermectin |
CN1985594B (en) * | 2006-12-04 | 2010-08-18 | 上海农乐生物制品股份有限公司 | Preparing process of rotenone water emulsion |
CN102037979A (en) * | 2010-10-26 | 2011-05-04 | 张炳泉 | Pesticide preparation for prevention and control of ticks |
CN101991522A (en) * | 2010-11-03 | 2011-03-30 | 华南理工大学 | Tick repellent toilet water and preparation method thereof |
CN101991522B (en) * | 2010-11-03 | 2012-08-22 | 华南理工大学 | Tick repellent toilet water and preparation method thereof |
CN102657712A (en) * | 2012-05-30 | 2012-09-12 | 中国农业科学院兰州畜牧与兽药研究所 | Preparation method for adonis coerulea maxim extract and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Szewc et al. | Biological methods for the control of gastrointestinal nematodes | |
Higgins | The camel in health and disease | |
EP1049378B1 (en) | An antimicrobial composition | |
Paterson et al. | Skin diseases of exotic pets | |
Higgins | 4. Common ectoparasites of the camel and their control | |
CN103783030A (en) | Method of controlling pests by combination of insect predator Carabussmaragdinus Fischer and Metarrhiziumanisopliae | |
CN101297650A (en) | Agent for preventing and controlling ectoparasite of animals | |
CN1278610C (en) | Externally used preparation for household pet disinsection and sterilization | |
Swinger | Managing external parasites of Texas cattle | |
CN104069070A (en) | Povidone-iodine powder with effective sterilization and disinfection effects and preparation method thereof | |
CN1401237A (en) | Animal ectoparasite preventing and treating agent | |
CN101810201A (en) | Biological preparation for preventing and treating nest insects | |
Cousquer | Veterinary care of rabbits with myiasis | |
CN111387218A (en) | Environment-friendly physical insecticide and preparation method thereof | |
MacLean et al. | Gruiformes (cranes, limpkins, rails, gallinules, coots, bustards) | |
CN112568224B (en) | Insecticidal composition containing chlorfenapyr flubendiamide and diafenthiuron | |
CN117084254B (en) | Composition suitable for killing ticks in animals and environment, and preparation method and application thereof | |
Barron | Appendix II Formulary for Common Wildlife Species | |
CN1711077A (en) | Combination product for controlling insect pests | |
CN115317498B (en) | Compound drop for treating canine and feline parasites and fungal skin diseases and preparation method thereof | |
Shrubsole-Cockwill et al. | Avian pox infection with secondary Candida albicans encephalitis in a juvenile golden eagle (Aquila chrysaetos) | |
Rodrigues et al. | Ectoparasitoses in Rabbits | |
Nedelchev Prelezov et al. | Pathomorphological changes in the tissues of chickens, experimentally infected with biting lice (Insecta: Phthiraptera) | |
Mavlanov et al. | Integrated methods of combating sheep ectoparasites | |
CN116806847B (en) | Active microbial agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |